Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function

<p><i>Comparisons of cystatin C levels in NSTE-ACS with or without Killip class &gt; 1 (a), high GRACE score (b), multivessel disease (c), high SYNTAX score (d), metabolic syndrome (e), and MACE (f) by using the Mann–Whitney U test.</i> MetS: metabolic syndrome; MACE: major adverse cardiovascular events.</p>

BioMed Research International

fig1

Figure 1

Figure 1: Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function 

Figure 1 | Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function 